Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Directed DNA Polymerase | 9 | 2021 | 199 | 1.870 |
Why?
|
| DNA Damage | 12 | 2024 | 1991 | 1.630 |
Why?
|
| DNA-Binding Proteins | 12 | 2024 | 5002 | 1.380 |
Why?
|
| DNA Repair | 11 | 2024 | 1910 | 1.320 |
Why?
|
| Mad2 Proteins | 4 | 2018 | 33 | 1.320 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 5 | 2024 | 437 | 0.940 |
Why?
|
| Genomic Instability | 4 | 2021 | 521 | 0.870 |
Why?
|
| DNA Replication | 5 | 2021 | 771 | 0.860 |
Why?
|
| Heterochromatin | 1 | 2021 | 90 | 0.770 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 5 | 2017 | 40 | 0.680 |
Why?
|
| Embryonic Stem Cells | 1 | 2021 | 278 | 0.660 |
Why?
|
| DNA Breaks, Double-Stranded | 6 | 2024 | 327 | 0.580 |
Why?
|
| BRCA1 Protein | 2 | 2018 | 528 | 0.510 |
Why?
|
| DNA | 3 | 2021 | 3051 | 0.500 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 1442 | 0.460 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 1958 | 0.440 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2024 | 3658 | 0.380 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 6 | 2018 | 43 | 0.380 |
Why?
|
| Cell Cycle Proteins | 4 | 2018 | 2116 | 0.380 |
Why?
|
| HeLa Cells | 5 | 2021 | 1685 | 0.380 |
Why?
|
| Ubiquitination | 2 | 2017 | 579 | 0.360 |
Why?
|
| Cell Line | 8 | 2021 | 5339 | 0.360 |
Why?
|
| Signal Transduction | 4 | 2024 | 12108 | 0.350 |
Why?
|
| Fanconi Anemia | 4 | 2017 | 90 | 0.350 |
Why?
|
| Proteins | 1 | 2018 | 2043 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 1471 | 0.330 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 809 | 0.330 |
Why?
|
| Replication Protein C | 1 | 2008 | 22 | 0.310 |
Why?
|
| Chromosomal Instability | 2 | 2021 | 229 | 0.290 |
Why?
|
| Fibroblasts | 4 | 2021 | 1656 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 385 | 0.260 |
Why?
|
| Duffy Blood-Group System | 1 | 2024 | 8 | 0.240 |
Why?
|
| Malaria, Vivax | 1 | 2024 | 9 | 0.240 |
Why?
|
| Plasmodium vivax | 1 | 2024 | 10 | 0.240 |
Why?
|
| Protozoan Proteins | 1 | 2024 | 123 | 0.220 |
Why?
|
| Protein Binding | 6 | 2024 | 3485 | 0.210 |
Why?
|
| Neoplasms | 2 | 2020 | 15933 | 0.210 |
Why?
|
| Phosphorylation | 4 | 2024 | 4945 | 0.200 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 255 | 0.190 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2021 | 32 | 0.190 |
Why?
|
| Cell Line, Transformed | 1 | 2021 | 427 | 0.190 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 904 | 0.180 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 747 | 0.180 |
Why?
|
| HEK293 Cells | 4 | 2018 | 1462 | 0.180 |
Why?
|
| Serum Albumin, Human | 1 | 2020 | 14 | 0.180 |
Why?
|
| Serum Albumin, Bovine | 1 | 2020 | 84 | 0.180 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2018 | 8 | 0.160 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 1569 | 0.160 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 10709 | 0.160 |
Why?
|
| M Phase Cell Cycle Checkpoints | 2 | 2016 | 30 | 0.160 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2018 | 88 | 0.150 |
Why?
|
| Gold | 1 | 2020 | 267 | 0.150 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 184 | 0.150 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 92 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 14853 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2021 | 1503 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2018 | 256 | 0.140 |
Why?
|
| Animals | 14 | 2021 | 62063 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2021 | 700 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 806 | 0.130 |
Why?
|
| Cross-Linking Reagents | 2 | 2014 | 167 | 0.130 |
Why?
|
| Nucleotidyltransferases | 2 | 2021 | 96 | 0.120 |
Why?
|
| Zebrafish Proteins | 1 | 2015 | 155 | 0.120 |
Why?
|
| Humans | 19 | 2024 | 271010 | 0.110 |
Why?
|
| Replication Protein A | 1 | 2013 | 37 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2013 | 1082 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4224 | 0.110 |
Why?
|
| Embryonic Development | 1 | 2016 | 310 | 0.110 |
Why?
|
| DNA, Single-Stranded | 1 | 2013 | 124 | 0.110 |
Why?
|
| Cell Survival | 2 | 2016 | 3066 | 0.110 |
Why?
|
| Rad51 Recombinase | 1 | 2013 | 125 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 7104 | 0.100 |
Why?
|
| Testis | 1 | 2015 | 620 | 0.100 |
Why?
|
| Chromatin | 2 | 2018 | 1046 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2010 | 271 | 0.090 |
Why?
|
| Binding Sites | 1 | 2015 | 2256 | 0.090 |
Why?
|
| DNA Helicases | 1 | 2013 | 450 | 0.090 |
Why?
|
| Mice | 6 | 2021 | 35608 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2021 | 7239 | 0.080 |
Why?
|
| Histones | 1 | 2016 | 1513 | 0.080 |
Why?
|
| Chickens | 3 | 2017 | 783 | 0.080 |
Why?
|
| Oxidants | 1 | 2008 | 50 | 0.080 |
Why?
|
| Ligases | 1 | 2008 | 82 | 0.070 |
Why?
|
| Alkylating Agents | 1 | 2008 | 81 | 0.070 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2008 | 96 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 199 | 0.070 |
Why?
|
| Mutation | 6 | 2018 | 15915 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 223 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 657 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2014 | 2100 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 906 | 0.060 |
Why?
|
| Ethiopia | 1 | 2024 | 29 | 0.060 |
Why?
|
| Membrane Proteins | 3 | 2024 | 2932 | 0.060 |
Why?
|
| Antigens, Protozoan | 1 | 2024 | 72 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 4134 | 0.060 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 3440 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2175 | 0.060 |
Why?
|
| Calreticulin | 1 | 2003 | 86 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 876 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1193 | 0.050 |
Why?
|
| Anesthetics | 1 | 2003 | 118 | 0.050 |
Why?
|
| Sex Differentiation | 1 | 2000 | 41 | 0.040 |
Why?
|
| Transfection | 3 | 2014 | 3118 | 0.040 |
Why?
|
| Luminescence | 1 | 2020 | 45 | 0.040 |
Why?
|
| Chemokines | 1 | 2021 | 290 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4821 | 0.040 |
Why?
|
| Muscles | 1 | 2000 | 456 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 323 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2016 | 3029 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2003 | 866 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2018 | 157 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2000 | 427 | 0.040 |
Why?
|
| Aflatoxin B1 | 1 | 2016 | 8 | 0.040 |
Why?
|
| Aflatoxins | 1 | 2016 | 14 | 0.040 |
Why?
|
| Cytidine | 1 | 2016 | 24 | 0.040 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2017 | 71 | 0.030 |
Why?
|
| Benomyl | 1 | 2016 | 4 | 0.030 |
Why?
|
| Cdc20 Proteins | 1 | 2016 | 26 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 6686 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 354 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2016 | 65 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2016 | 111 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2016 | 214 | 0.030 |
Why?
|
| Genes, Overlapping | 1 | 2015 | 15 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 108 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 63 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 183 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 519 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2014 | 52 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2016 | 610 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 625 | 0.030 |
Why?
|
| DNA End-Joining Repair | 1 | 2014 | 92 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 116 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2014 | 5698 | 0.030 |
Why?
|
| Cisplatin | 1 | 2021 | 2497 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 576 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 655 | 0.030 |
Why?
|
| Bleomycin | 1 | 2014 | 482 | 0.030 |
Why?
|
| Sister Chromatid Exchange | 1 | 2013 | 45 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 1255 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 460 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2015 | 665 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1582 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 470 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 341 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 457 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2016 | 662 | 0.030 |
Why?
|
| Gene Expression | 1 | 2000 | 3643 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2015 | 611 | 0.030 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2013 | 169 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1111 | 0.020 |
Why?
|
| Transcriptome | 1 | 2021 | 1962 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 269 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 234 | 0.020 |
Why?
|
| Mitomycin | 1 | 2013 | 213 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 1383 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2018 | 950 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 5759 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 5731 | 0.020 |
Why?
|
| Animals, Genetically Modified | 2 | 2003 | 411 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 968 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 2035 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2010 | 114 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 1811 | 0.020 |
Why?
|
| Yeasts | 1 | 2009 | 76 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4569 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2009 | 98 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 175 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2008 | 69 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2013 | 903 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 71 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 1424 | 0.020 |
Why?
|
| Caffeine | 1 | 2008 | 96 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 168 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 399 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2024 | 17068 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2008 | 331 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2000 | 5442 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 5437 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2665 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 22260 | 0.020 |
Why?
|
| Female | 5 | 2024 | 149107 | 0.020 |
Why?
|
| Male | 4 | 2024 | 128533 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 32777 | 0.010 |
Why?
|
| Child | 1 | 2024 | 30578 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 1642 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 2357 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2003 | 6398 | 0.010 |
Why?
|
| Pupa | 1 | 2000 | 25 | 0.010 |
Why?
|
| Muscle Development | 1 | 2000 | 88 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2000 | 113 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 2000 | 116 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1050 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 820 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2000 | 1431 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 82090 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2000 | 453 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 90433 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 4795 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 1028 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 5071 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 2602 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 3217 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 6517 | 0.010 |
Why?
|
| Neurons | 1 | 2000 | 2454 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 7665 | 0.010 |
Why?
|